These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26394703)

  • 1. The need for effective pancreatic cancer detection and management: a biomarker-based strategy.
    Crawley AS; O'Kennedy RJ
    Expert Rev Mol Diagn; 2015; 15(10):1339-53. PubMed ID: 26394703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular landscape of pancreatic cancer: challenges and clinical implications.
    Kyrochristos ID; Ziogas DE; Glantzounis GK; Roukos DH
    Future Oncol; 2017 Dec; 13(30):2741-2744. PubMed ID: 29182377
    [No Abstract]   [Full Text] [Related]  

  • 3. Caveolin-1: a marker for pancreatic cancer diagnosis.
    Tanase CP
    Expert Rev Mol Diagn; 2008 Jul; 8(4):395-404. PubMed ID: 18598222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma circulating tumor DNA in pancreatic adenocarcinoma for screening, diagnosis, prognosis, treatment and follow-up: A systematic review.
    Abdallah R; Taly V; Zhao S; Pietrasz D; Bachet JB; Basile D; Mas L; Zaanan A; Laurent-Puig P; Taieb J
    Cancer Treat Rev; 2020 Jul; 87():102028. PubMed ID: 32485509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment.
    Singh P; Srinivasan R; Wig JD
    Pancreas; 2011 Jul; 40(5):644-52. PubMed ID: 21673535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
    Urayama S
    World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for early detection of pancreatic cancer - miRNAs as a potential diagnostic and therapeutic tool?
    Tarasiuk A; Mackiewicz T; Małecka-Panas E; Fichna J
    Cancer Biol Ther; 2021 Jun; 22(5-6):347-356. PubMed ID: 34224317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of sporadic pancreatic cancer: summative review.
    Chari ST; Kelly K; Hollingsworth MA; Thayer SP; Ahlquist DA; Andersen DK; Batra SK; Brentnall TA; Canto M; Cleeter DF; Firpo MA; Gambhir SS; Go VL; Hines OJ; Kenner BJ; Klimstra DS; Lerch MM; Levy MJ; Maitra A; Mulvihill SJ; Petersen GM; Rhim AD; Simeone DM; Srivastava S; Tanaka M; Vinik AI; Wong D
    Pancreas; 2015 Jul; 44(5):693-712. PubMed ID: 25931254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for early pancreatic ductal adenocarcinoma: an urgent call!
    Lee MX; Saif MW
    JOP; 2009 Mar; 10(2):104-8. PubMed ID: 19287101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-Generation Sequencing in Pancreatic Cancer.
    Shen GQ; Aleassa EM; Walsh RM; Morris-Stiff G
    Pancreas; 2019 Jul; 48(6):739-748. PubMed ID: 31206465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular subtypes of pancreatic cancer.
    Collisson EA; Bailey P; Chang DK; Biankin AV
    Nat Rev Gastroenterol Hepatol; 2019 Apr; 16(4):207-220. PubMed ID: 30718832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward a better understanding of pancreatic ductal adenocarcinoma: glimmers of hope?
    Partensky C
    Pancreas; 2013 Jul; 42(5):729-39. PubMed ID: 23648843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarker-Based Therapy in Pancreatic Ductal Adenocarcinoma: An Emerging Reality?
    Krantz BA; O'Reilly EM
    Clin Cancer Res; 2018 May; 24(10):2241-2250. PubMed ID: 29269376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of sporadic pancreatic cancer: strategic map for innovation--a white paper.
    Kenner BJ; Chari ST; Cleeter DF; Go VL
    Pancreas; 2015 Jul; 44(5):686-92. PubMed ID: 25938853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in proteomically subtyping pancreatic ductal adenocarcinomas and their potential clinical impact.
    Roesli C
    Expert Rev Proteomics; 2015 Feb; 12(1):5-8. PubMed ID: 25407217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?
    Mardin WA; Mees ST
    Ann Surg Oncol; 2009 Nov; 16(11):3183-9. PubMed ID: 19636633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing on pancreatic cancer.
    Nat Rev Gastroenterol Hepatol; 2021 Jul; 18(7):447. PubMed ID: 34188210
    [No Abstract]   [Full Text] [Related]  

  • 18. Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment?
    Papadakos SP; Dedes N; Pergaris A; Gazouli M; Theocharis S
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoassay-based proteome profiling of 24 pancreatic cancer cell lines.
    Alhamdani MS; Youns M; Buchholz M; Gress TM; Beckers MC; Maréchal D; Bauer A; Schröder C; Hoheisel JD
    J Proteomics; 2012 Jun; 75(12):3747-59. PubMed ID: 22579748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular markers in pancreatic cancer diagnosis.
    Herreros-Villanueva M; Gironella M; Castells A; Bujanda L
    Clin Chim Acta; 2013 Mar; 418():22-9. PubMed ID: 23305796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.